Skip to main content
. Author manuscript; available in PMC: 2022 Jun 20.
Published in final edited form as: J Surg Oncol. 2012 May 24;106(5):532–542. doi: 10.1002/jso.23162

TABLE II.

Sensitivity of Detection of Benign Pheochromocytoma/Paraganglioma

Reference Patient-based sensitivity (lesion-based sensitivity in parenthesis)

Number of patientsa MIBG SRS FDG FDA FDOPA CT MRI
[110] 48 98%b
[111] 32 90.6%b 90% 93.3%
[66] 17 87.5%b 28.5% 87.5% 100%c 100%c
[112] 32 (25%)
[68] 12 83%d 58%
[57] 7 VHL 57%d 100% 100% 83%
[54] 20 (77%)b (88%) (77%) (81%) (100%)c (100%)c
[69] 17 71%b 100% 100%
[71] 24 (52%)e (85%) (70%)c (70%)c
[113] 22 100% 66%
[63] 25 (53%)b 97%
a

Data for benign PGL only, some studies included both benign and malignant PGL.

b

I-123 MIBG.

c

Studies used either CT or MRI.

d

Either I-123 or I-131 MIBG.

e

I-131 MIBG.